Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “TREAT”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 217 records · Page 12

Effects of Boron and Graphite Uncertainty in Fuel for TREAT Simulations

Advanced modeling techniques and current computational capacity make full core TREAT simulations possible, with the goal of such simulations to understand the pre-test core and minimize the number of required calibrations. But, in order to simulate TREAT with a high degree of precision the reactor materials and geometry must also be modeled with a high degree of precision. This paper examines how uncertainty in the reported values of boron and graphite have an effect on simulations of TREAT.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

OPTIMIZATION OPTIONS FOR NARROWING TRANSIENT TESTING PULSE WIDTHS NECESSARY TO ENHANCE LWR RIA SIMULATIONS IN THE TREAT FACILITY

The Transient Reactor Test (TREAT) Facility provided thousands of transient irradiations and plays a crucial role in nuclear-heated safety research. The facility’s flexible design and multi-mission nature saw historic experiments for numerous reactor fuels and transient types, but was never specifically adapted to address very-brief pulse transients akin to postulated Light Water Reactor (LWR) Reactivity Initiated Accidents (RIA). Since the behaviors of fuel under these conditions depends strongly on energy input duration and resulting cladding time/temperature response under pellet cladding mechanical interactions, this three-year project was conceived to investigate new pulse-narrowing capabilities. Kinetic models showed incremental improvements for minor facility enhancements including increased reactivity step insertions (to initiate the power pulse) and slightly-increased transient rod drive speed for pulse termination (“clipping”). Replacing peak fuel assemblies, repositioning non-transient control rods to hold down the “hot side” of the core, and balancing against required excess reactivity needs, the limiting fuel assembly power can be reduced by ~20 %. This is a remarkable discovery of latent capability in TREAT, not only in enabling the subject capabilities for reduced pulse widths, but also significantly “uprating” the core’s transient energy capacity. Incremental improvements can likely enhance TREAT’s capability into BWR-relevant missions; briefer PWR pulse shapes can only be achieved with an advanced clipping system. Helium 3 was found to offer the greatest benefits for clipping design and overall performance. A unique concept showed great promise for enabling a 3He-based system with a reasonable cost; this design concept will likely become the focal point of future work.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Evaluation, Refurbishment, and Characterization of Fast Neutron Scintillators for the TREAT Fuel Motion Monitoring System

This paper details work being performed at the Idaho National Laboratory (INL) to evaluate, refurbish, and characterize proton-recoil scintillation (PRS) detectors utilized in a 360 channel array for the measurement of fast neutrons in a standalone system historically called a hodoscope located in the Transient Reactor Test Facility (TREAT). The TREAT hodoscope serves as the primary Fuel Motion Monitoring System for documenting real time fuel displacement during transient experiments. The detectors in the hodoscope have stood dormant for over 20 years and significant degradation must be addressed before the system can be brought back to operational status. The refurbishment process begins by decoupling the PRS from their matched photo multiplier tubes (PMTs) and treating the PRS with ethanol. This process cleans the surfaces, removing paint and legacy labels/ markings. During this procedure many physical variations can be observed. After cleaning, the PRS are physically measured using a digital caliper and the dimensions documented. Following this, a well-controlled 280nm LED light source is used to stimulate the PRS to produce an emission spectrum inside an integration sphere. This emission spectrum is then measured using a UV enhanced optical spectrometer. Spectral measurements are recorded from 185 nm to 580 nm in 0.4 nm steps. The PRS are then lightly sanded on the non-PMT mating surfaces and painted with commercially available reflective paint. A final emission spectrum is recorded for each PRS after painting.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

TREAT Multi-SERTTA Neutronics Design and Analysis Support

Transient Reactor Experiment Test (TREAT) experiment vehicle design is necessary in preparation for TREAT facility restart and the resumption of transient testing to support current Accident Tolerant Fuel (ATF) characterization needs and future fuels testing requirements. Currently the most mature vehicle design is the Multi-SERTTA (Static Environments Rodlet Transient Test Apparatuses), which can accommodate up to four concurrent rodlet-sized specimens under separate environmental conditions. Development of this robust test vehicle design requires neutronics analyses to support optimization of the Power Coupling Factor (PCF) to efficiently maximize energy generation in the fuel rodlets and to perform essential safety analyses. Current Multi-SERTTA calculations support final design of this vehicle, the design process for other TREAT vehicles, and the development of analyses practices for upcoming transient testing experiments. Models of the preliminary design Multi-SERTTA vehicle with rodlets were prepared and neutronics calculations were performed using MCNP6.1 with ENDF/B-VII.1 nuclear data libraries. Discussion of results.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Transient Reactor Test Facility (TREAT) Low Enriched Uranium (LEU) Conversion Progress

The National Nuclear Security Administration Office of Material Management and Minimization (NNSA M3) is working towards converting the Transient Reactor Test Facility (TREAT) located at the Idaho National Laboratory (INL) from its original high-enriched uranium (HEU) core to a low-enriched uranium (LEU) core. TREAT reactor operations were restarted in November of 2017 and data obtained from the initial testing will be used to validate the existing ANL reactor modeling. Fuel block development has progressed with the completion of 2 and 4 inch crack free surrogate fuel blocks. Alternative fabrication methods for the fuel blocks continue to be explored and are showing promising results. Additionally, cladding oxidation studies have been performed and analyzed to initiate the down selection of cladding material to be used for the TREAT LEU fuel elements. This paper describes the current status of the above mentioned activities, and discusses the anticipated path forward for the conversion program as it progresses toward a final fuel design and fuel fabrication process.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

FEASIBILITY ASSESSMENT FOR DEVELOPING AN INTEGRAL LOCA TESTING CAPABILITY AT THE TRANSIENT RESEARCH TEST (TREAT) REACTOR

The study of Light Water Reactor (LWR) fuel performance in Loss of Coolant Accidents (LOCAs) has been a significant and evolving field since the beginning of the commercialization of LWR technology. The following paper presents the results of feasibility assessment to develop an in-pile, integral LOCA testing capability using the recently restarted TREAT reactor located at the Idaho National Laboratory (INL). Critical performance objectives for the testing platform are derived from a review of known LWR fuel degradation phenomena in LOCA scenarios. Advanced modeling and simulation tools were then used to gain additional insight into both the system performance and fuel performance characteristics of LOCA testing at TREAT. Results show that TREAT is well suited to conduct in-pile integral LOCA testing.

42 ENGINEERING↗

Performance Prediction of Irradiated TREAT Fuel

Poster Title: Performance Prediction of Irradiated TREAT Fuel The poster presents findings about the irradiation damage layer effects on the microscopic fuel temperature profile in TREAT. Microscopic fuel particles in TREAT are small enough that fission fragments travel out of the particles causing thermal property reduction in a shell around the fuel particle. The use of Magpie and MAMMOTH code is illustrated. The thermal temperature solution is simulated using EOS pulse power data. The reduction of microscopic fuel particle size reduced the irradiation damage due to fission fragments. The reduction of fission events is shown to be greater than the increase in fission fragments leaving the particle as size decreases. The temperature difference between the microscopic fuel particle and bulk graphite is shown to increase with irradiation as the damage layer grows.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

TREAT Experiments: Sweetening Nuclear Fuels Research Through the Use of Additive Manufacturing

Since being restarted in late summer of 2017 TREAT has already completed multiple experiment campaigns. In addition, TREAT experiment designs have been pushing the envelope for use of additive manufacturing in the nuclear fuels research. The use of additive manufacturing for TREAT experiments has lowered the cost and allowed for intricate experiment design and capability. This presentation shows how additive manufacturing was used for some of the various experiments as well as future planned uses.

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Evaluation of MSNDs for Fast-Neutron Detection and the TREAT Hodoscope

The need for next-generation, accident-tolerant fuels has generated significant interest in the restart of domestic fuels testing at the Transient Reactor Test (TREAT) facility. A key feature of the TREAT reactor core is an open, horizontal channel that allows line-of-sight viewing of test specimens using various instrumentation during steady-state and transient operation. This instrumentation includes the hodoscope, which consists of over 300 steel-collimated channels coupled to Hornyak buttons (and other detectors) for detection of fast neutrons emitted from fission of the test specimen. Posterior analysis can be used to reconstruct fuel motion and other properties from the collimated channel signals. A large-scale effort is underway to develop next generation instrumentation for transient testing at TREAT (and, potentially, other facilities). Work at KSU specifically aims to provide improved detection systems for hodoscope applications. It was initially proposed to adapt KSU-developed Microstructured Semiconductor Neutron Detectors (MSNDs) for use as fast-neutron detectors. The current generation of MSNDs is designed for thermal-neutron detection based on {sup 6}Li and can achieve intrinsic efficiencies nearing 30% owing to the large (n, t) cross section of {sup 6}Li and clever optimization of the geometry. In order to evaluate MSNDs for fast-neutron detection, two approaches were considered: (1) use of a hydrogenous material to thermalize neutrons to exploit the intrinsic efficiencies of current MSNDs, and (2) substitution of a fast-sensitive reactant for {sup 6}Li. The former approach is attractive because it makes use of proven, off-the-shelf technology and leads to reasonable time resolution and efficiency. Unfortunately, use of thermalization leads to prohibitive degradation of spatial resolution. The second approach will require further experimental efforts, but scoping analyses suggest {sup 235}U- or {sup 237}Th-loaded MSNDs may achieve sufficient efficiencies. The rest of this summary examines these issues in more detail. (authors)

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Transient Reactor Test Facility (TREAT) Startup Status

Transient testing is critical for understanding how new fuels perform in accident conditions such as transient overpower and/or under cooling events. In February of 2014, The U.S. Department of Energy (DOE) determined that a Finding of No Significant Impact (FONSI) was appropriate for the resumption of transient testing of nuclear fuels and materials. At that point, work began on the restart of the Transient Reactor Test Facility (TREAT), which was the DOE preferred alternative for reestablishing transient testing capability for nuclear fuels and materials in the U.S. Significant progress has been made in the restart of TREAT for transient testing since the FONSI in 2014. The progress made since 2014 towards restarting TREAT and the current status is documented in this summary. (author)

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Investigation of Treat M2 and M3 calibration experiments for benchmark analysis

The Transient Reactor Test Facility (TREAT) located at Idaho National Laboratory is a graphite moderated and reflected, air cooled core. This reactor was originally designed and operated to experimentally test fuel under extreme transient conditions. To this end, TREAT successfully performed many series of steady-state and transient tests until operations were discontinued in 1994. With the restart of the reactor planned for 2018, accurate models of previous reactor experiments are necessary to verify the ability to predict conditions for planned upcoming tests. In this work, the methodology for modeling the M2 and M3 calibration experiments (M2/M3CAL) will be described along with results from the variation of key parameters including the boron concentration. Additionally, this model will be used to demonstrate the correlation between reactor behavior and the implementation of 'nuclear graphite' thermal scattering law (TSL) data to capture the behavior of thermal neutrons in the TREAT core.

21 SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS↗

Impact of the delayed energy deposition in TREAT on transient dynamics

Estimating the energy released during a reactivity insertion accident (RIA) is of prime importance. TREAT is an experimental reactor designed to simulate these transients. Typically, models of these transients assume instantaneous energy deposition. However, a delayed energy deposition component exists. This work leverages the advanced capabilities of ALFRED, a high-fidelity Monte Carlo code for particle transport, to study the impact of this delayed component on RIA transient dynamics in TREAT. The study reveals that the delayed component can affect the energy released by up to $3\%$ for natural pulse transients. Understanding the impact of the delayed energy deposition component will enable the development of more accurate models, which will assist in designing experiments in TREAT and evaluating their safety.

73 - NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor

Purpose: To investigate the frequency and imaging features of radiographically evident abdominal immune-related adverse events (irAEs) in patients with metastatic non-small-cell lung cancer (NSCLC) treated with PD-1 inhibitors. Methods: This retrospective study included 137 patients with metastatic NSCLC treated with PD-1 inhibitor nivolumab monotherapy (75 women; median age: 65 years), who had a baseline CT and at least one follow-up abdomen CT during therapy. Baseline and all follow-up abdominal CTs performed for monitoring of nivolumab therapy were reviewed to identify the organ-specific abdominal irAEs including colitis/enteritis, hepatitis, biliary toxicity, pancreatitis, nephritis, sarcoid-like reaction, and pancreatic and adrenal atrophy. Their frequency and imaging features were described. Results: Eighteen (13%) patients had radiologically identified abdominal irAEs (median 2.1 months after starting nivolumab; interquartile range 1.17–5.83 months); 16 patients developed enteritis/colitis (12 pancolitis, two segmental colitis, one enterocolitis, one enteritis), two hepatitis, one adrenalitis. One patient with hepatitis also developed colitis/enteritis. Radiographic abdominal irAE occurred after nivolumab therapy was discontinued in six patients before any subsequent therapy was started. IrAEs prompted nivolumab interruption and treatment with steroids in four patients (three colitis/enteritis, one hepatitis). Most common CT features of colitis/enteritis included mesenteric hyperemia (n = 15), bowel wall thickening (n = 13), mucosal hyperenhancement (n = 10), and fluid-filled colon (n = 9). Conclusion: Abdominal irAEs were detected on CT in 13% of NSCLC patients treated with nivolumab, and colitis, in the pancolitis form, was the most common irAE. Given the expanding role of immunotherapy, radiologists should be aware of the frequency and imaging manifestations of abdominal irAEs and the impact on patient management.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Investigation of the Hemodynamic Effect of Stent Wires on Renal Arteries in Patients with Abdominal Aortic Aneurysms Treated with Suprarenal Stent-Grafts

The purpose of the study was to investigate the hemodynamic effect of stent struts (wires) on renal arteries in patients with abdominal aortic aneurysms (AAAs) treated with suprarenal stent-grafts. Two sample patients with AAA undergoing multislice CT angiography pre- and postsuprarenal fixation of stent-grafts were selected for inclusion in the study. Eight juxtarenal models focusing on the renal arteries were generated from the multislice CT datasets. Four types of configurations of stent wires crossing the renal artery ostium were simulated in the segmented aorta models: a single wire crossing centrally, a single wire crossing peripherally, a V-shaped wire crossing centrally, and multiple wires crossing peripherally. The blood flow pattern, flow velocity, wall pressure, and wall shear stress at the renal arteries pre- and post-stent-grafting were analyzed and compared using a two-way fluid structure interaction analysis. The stent wire thickness was simulated with a diameter of 0.4, 1.0, and 2.0 mm, and hemodynamic analysis was performed at different cardiac cycles. The interference of stent wires with renal blood flow was mainly determined by the thickness of stent wires and the type of configuration of stent wires crossing the renal ostium. The flow velocity was reduced by 20-30% in most of the situations when the stent wire thickness increased to 1.0 and 2.0 mm. Of the four types of configuration, the single wire crossing centrally resulted in the highest reduction of flow velocity, ranging from 21% to 28.9% among three different wire thicknesses. Wall shear stress was also dependent on the wire thickness, which decreased significantly when the wire thickness reached 1.0 and 2.0 mm. In conclusion, our preliminary study showed that the hemodynamic effect of suprarenal stent wires in patients with AAA treated with suprarenal stent-grafts was determined by the thickness of suprarenal stent wires. Research findings in our study are useful for follow-up of patients treated with suprarenal stent-grafts to ensure long-term safety of the suprarenal fixation.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up

Purpose: To describe the morphologic evolution of lung tumors treated with radiofrequency ablation (RFA) by way of computed tomography (CT) images and to investigate patterns of incomplete RFA at the site of ablation. Materials and Methods: One hundred eighty-nine patients with 350 lung tumors treated with RFA underwent CT imaging at 2, 4, 6, and 12 months. CT findings were interpreted separately by two reviewers with consensus. Five different radiologic patterns were predefined: fibrosis, cavitation, nodule, atelectasis, and disappearance. The appearance of the treated area was evaluated at each follow-up CT using the predefined patterns. Results: At 1 year after treatment, the most common evolutions were fibrosis (50.5%) or nodules (44.8%). Differences were noted depending on the initial size of the tumor, with fibrosis occurring more frequently for tumors <2 cm (58.6% vs. 22.9%, P = 1 Multiplication-Sign 10{sup -5}). Cavitation and atelectasis were less frequent patterns (2.4% and 1.4%, respectively, at 1 year). Tumor location (intraparenchymatous, with pleural contact <50% or >50%) was not significantly correlated with follow-up image pattern. Local tumor progressions were observed with each type of evolution. At 1 year, 12 local recurrences were noted: 2 cavitations, which represented 40% of the cavitations noted at 1 year; 2 fibroses (1.9%); 7 nodules (7.4%); and 1 atelectasis (33.3%). Conclusion: After RFA of lung tumors, follow-up CT scans show that the shape of the treatment zone can evolve in five different patterns. None of these patterns, however, can confirm the absence of further local tumor progression at subsequent follow-up.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Long-Term Single-Center Retrospective Follow-Up After Embolization of Pulmonary Arteriovenous Malformations Treated Over a 20-year Period: Frequency of Re-canalization with Various Embolization Materials and Clinical Outcome

Purpose: The present study is a register-based observational study of an unselected consecutive patient cohort with pulmonary arteriovenous malformations (PAVMs) from a single national hereditary hemorrhagic telangiectasia and PAVM embolization center. The aim was to investigate the frequency of re-embolizations and the clinical outcome after embolization with the use of different embolization materials further, to define which PAVM morphology and size of feeding arteries that most often were re-embolized, and to estimate the clinical outcome of the patients including those that were re-embolized. Methods: The population was included from 1996 until 2016 and was made up of a total of 136 patients with 322 PAVMs. Median follow-up was 38.3 (0.3–241 months). Results: The re-embolization rate was 9.3%. None of the PAVMs treated with detachable silicone balloons were re-embolized, while 4.5% treated with vascular plugs and 11.7% treated with coils were re-embolized (p=0.07). In total, 16/74 complex PAVMs were re-embolized compared with 14/248 simple PAVMs. In big-sized feeding arteries ≥ 6mm, 16/112 were re-embolized compared with 14/210 with smaller-sized feeding arteries. Out of the 30 re-embolized PAVMs, 23 resulted in a successful clinical outcome. Conclusions: Our results suggest that standard coils probably should not be the first choice for embolization of PAVMs, and vascular plug alone or in combination with coils might be a better primary option for embolization in these patients. Level of Evidence: Level 3A, non-randomized case controlled cohort/follow-up study.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Long-Term Leaching Effect on Decay Resistance of Wood-Plastic Composites Treated with Boron Compounds

In this study, water absorption, thickness swelling and decay resistance of thermoplastic composites treated with three types of boron compounds was investigated. Spruce wood flour was treated with boric acid (BA), borax (BX) and mixture of BA–BX, and then was reinforced at two loading rate (20 and 40 wt%) in polymer matrix. Decay test of the composites was performed using with a brown rot fungus Coniophora puteana and a white rot fungus Trametes versicolor both for leached and unleached samples. The morphologic evaluations of decayed samples were done by scanning electron microscopy. Composites containing higher wood flour loading resulted in increased water absorption, thickness swelling, weight loss and moisture content. Fungal decay susceptibility of WPCs was influenced by leaching test for 60 days. Boron compound treated composites showed higher weight loss and moisture content than controls in decay test. All tested performance parameters were considerably increased in BX containing composites.

36 MATERIALS SCIENCE↗

Klotho down-regulates Egr-1 by inhibiting TGF-β1/Smad3 signaling in high glucose treated human mesangial cells

Diabetic kidney disease (DKD) has become the leading cause of end-stage renal disease worldwide and is associated with glomerular mesangial cell (MC) proliferation and excessive extracellular matrix (ECM) production. Klotho can attenuate renal fibrosis in part by inhibiting TGF-β1/Smad3 signaling in DKD. Early growth response factor 1 (Egr-1) has been shown to play a key role in renal fibrosis in part by facilitating the formation of a positive feedback loop involving TGF-β1. However, whether Klotho down-regulates Egr-1 by inhibiting TGF-β1/Smad3 signaling in DKD is unclear. In the present study, we assessed human MCs that were incubated under high-glucose conditions to mimic diabetes. Then, we transfected the cells with Klotho plasmid or siRNA to overexpress or knock down Klotho gene and protein expression. Klotho, Egr-1, fibronectin (FN), collagen type I (Col I), Smad3 and phosphorylated Smad3 (p-Smad3) gene and protein expression levels were determined by RT-qPCR and western blotting respectively. High glucose time-dependently down-regulated Klotho mRNA and protein expression in cultured human MCs. pcDNA3.1-Klotho transfection-mediated Klotho overexpression down-regulated Egr-1, FN and Col I expression and the p-Smad3/Smad3 ratio in human MCs. Conversely, siRNA-mediated Klotho silencing up-regulated Egr-1, FN, and Col I expression and the p-Smad3/Smad3 ratio. Moreover, the effects of si-Klotho on Egr-1 expression were abolished by the TGF-β1 inhibitor SB-431542. Klotho overexpression can prevent mesangial ECM production in high-glucose-treated human MCs, an effect that has been partially attributed to Egr-1 down-regulation facilitated by TGF-β1/Smad3 signaling inhibition. - Highlights: • High glucose time-dependently down-regulated Klotho mRNA and protein expression in cultured human MCs. • Klotho overexpression down-regulated Egr-1 and prevented mesangial ECM production in high-glucose-treated human MCs. • Klotho down-regulated Egr-1 by inhibiting TGF-β1/Smad3 signaling in high-glucose-treated human MCs.

60 APPLIED LIFE SCIENCES↗